WallStreetZen

NASDAQ: CLGN
CollPlant Biotechnologies Ltd Stock Forecast, Predictions & Price Target

Analyst price target for CLGN

Based on 1 analysts offering 12 month price targets for CollPlant Biotechnologies Ltd.
Min Forecast
$26.00+47.81%
Avg Forecast
$26.00+47.81%
Max Forecast
$26.00+47.81%

Should I buy or sell CLGN stock?

Based on 1 analysts offering ratings for CollPlant Biotechnologies Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

CLGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 3%
98
BuyMaintains$26.00+47.81%2021-02-09

1 of 1

Forecast return on equity

Is CLGN forecast to generate an efficient return?
Company
75.65%
Industry
21.88%
Market
37.5%
CLGN's Return on Equity is forecast to be high in 3 years (75.65%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is CLGN forecast to generate an efficient return on assets?
Company
68.38%
Industry
6.66%
CLGN is forecast to generate higher Return on Assets (68.38%) than the US Biotechnology industry average (6.66%)
Forecast

CLGN earnings per share forecast

What is CLGN's earnings per share in the next 3 years based on estimates from 1 analysts?
Avg 1 year Forecast
$0.20+5.26%
Avg 2 year Forecast
$1.90+900%
Avg 3 year Forecast
$3.88+1,942.11%
CLGN's earnings are forecast to grow at an exceptional rate of 173.33% per year
Forecast

CLGN revenue forecast

What is CLGN's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$15.5M-2.47%
Avg 2 year Forecast
$49.2M+209.79%
Avg 3 year Forecast
$70.4M+343.23%
CLGN's revenue is forecast to grow at an exceptional rate of 64.26% per year
Forecast

CLGN earnings growth forecast

How is CLGN forecast to perform vs Biotechnology companies and vs the US market?
Company
173.33%
Industry
6.78%
Market
14.37%
CLGN's earnings are forecast to grow faster (173.33% per year) than the US Biotechnology industry average (6.78%)
Forecast
CLGN's earnings are forecast to grow faster (173.33% per year) than the US market average (14.37%)
Forecast
CLGN's earnings are forecast to grow faster (173.33% per year) than the risk-free savings rate (1.4%)
Forecast

CLGN revenue growth forecast

How is CLGN forecast to perform vs Biotechnology companies and vs the US market?
Company
64.26%
Industry
30.03%
Market
10.08%
CLGN's revenues are forecast to grow faster (64.26% per year) than the US Biotechnology industry average (30.03%)
Forecast
CLGN's revenues are forecast to grow faster (64.26% per year) than the US market average (10.08%)
Forecast

CollPlant Biotechnologies Ltd Stock Forecast FAQ

Is CollPlant Biotechnologies Ltd Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 1 Wall Street analysts covering (NASDAQ: CLGN) stock is to Buy CLGN stock.

Out of 1 analysts, 0 (0%) are recommending CLGN as a Strong Buy, 1 (100%) are recommending CLGN as a Buy, 0 (0%) are recommending CLGN as a Hold, 0 (0%) are recommending CLGN as a Sell, and 0 (0%) are recommending CLGN as a Strong Sell.

What is CLGN's earnings growth forecast for 2021-2023?

(NASDAQ: CLGN) CollPlant Biotechnologies Ltd's forecast annual earnings growth rate of 173.33% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.78%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 14.37%.

CollPlant Biotechnologies Ltd's earnings in 2021 is $1,104,000.On average, 1 Wall Street analysts forecast CLGN's earnings for 2021 to be $2,138,324, with the lowest CLGN earnings forecast at $2,138,324, and the highest CLGN earnings forecast at $2,138,324. On average, 2 Wall Street analysts forecast CLGN's earnings for 2022 to be $20,314,082, with the lowest CLGN earnings forecast at $19,138,003, and the highest CLGN earnings forecast at $21,490,160.

In 2023, CLGN is forecast to generate $41,483,493 in earnings, with the lowest earnings forecast at $5,131,979 and the highest earnings forecast at $77,835,008.

What is CLGN's revenue growth forecast for 2021-2023?

(NASDAQ: CLGN) CollPlant Biotechnologies Ltd's forecast annual revenue growth rate of 64.26% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.03%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.

CollPlant Biotechnologies Ltd's revenue in 2021 is $15,888,000.On average, 2 Wall Street analysts forecast CLGN's revenue for 2021 to be $165,666,683, with the lowest CLGN revenue forecast at $162,405,738, and the highest CLGN revenue forecast at $168,927,628. On average, 2 Wall Street analysts forecast CLGN's revenue for 2022 to be $526,241,635, with the lowest CLGN revenue forecast at $451,186,448, and the highest CLGN revenue forecast at $601,296,821.

In 2023, CLGN is forecast to generate $752,904,021 in revenue, with the lowest revenue forecast at $250,504,703 and the highest revenue forecast at $1,255,303,339.

What is CLGN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: CLGN) forecast ROA is 68.38%, which is higher than the forecast US Biotechnology industry average of 6.66%.

What is CLGN's Price Target?

According to 1 Wall Street analysts that have issued a 1 year CLGN price target, the average CLGN price target is $26.00, with the highest CLGN stock price forecast at $26.00 and the lowest CLGN stock price forecast at $26.00.

On average, Wall Street analysts predict that CollPlant Biotechnologies Ltd's share price could stay at $26.00 by Feb 9, 2022. The average CollPlant Biotechnologies Ltd stock price prediction forecasts a potential downside of N/A from the current CLGN share price of $17.59.

What is CLGN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: CLGN) CollPlant Biotechnologies Ltd's current Earnings Per Share (EPS) is $0.19. On average, analysts forecast that CLGN's EPS will be $0.20 for 2021, with the lowest EPS forecast at $0.20, and the highest EPS forecast at $0.20. On average, analysts forecast that CLGN's EPS will be $1.90 for 2022, with the lowest EPS forecast at $1.79, and the highest EPS forecast at $2.01. In 2023, CLGN's EPS is forecast to hit $3.88 (min: $0.48, max: $7.28).

What is CLGN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: CLGN) forecast ROE is 75.65%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.